Polymyxin B (PMB) is known to require reactive oxygen species (ROS) for its bactericidal activity, but the mechanism of PMB resistance in various Pseudomonas aeruginosa strains has been poorly understood. This study examined the role of nitrate respiration (NR) of some P. aeruginosa strains in the PMB resistance.
Results:
We observed that the minimum inhibitory concentration (MIC) value of PMB against P. aeruginosa PA14 was eightfold reduced (from 2.0 to 0.25 μg/mL) by agitation, but not against P. aeruginosa PAO1 (from 2.0 to 1.0 μg/mL). Transcriptomic and phenotypic analyses using both strains and their NR mutants revealed that the higher NR in PAO1 than in PA14 accounted for the higher MIC value (i.e., PMB resistance) of PAO1, which was sufficient to compromise the antibacterial activity of PMB in Drosophila infections. We also confirmed the contribution of the NR to the PMB resistance is independent of the major catalase (KatA), suggesting that the NR might affect the ROS generation rather than the ROS disintegration. Furthermore, this PMB resistance was relatively common among clinical P. aeruginosa isolates and correlated with higher NR in those strains.
Innovation and Conclusion:
These results suggest P. aeruginosa strains could display intrinsic resistance to antibiotics in clinical settings and that NR is a crucial factor in the intrinsic antibiotic resistance, and also provide an insight into another key target for successful antibiotic treatment of P. aeruginosa infections. Antioxid. Redox Signal. 34, 442–451.
Get full access to this article
View all access options for this article.
References
1.
AbdelraoufK, BraggsKH, YinT, TruongLD, HuM, and TamVH. Characterization of polymyxin B-induced nephrotoxicity: implications for dosing regimen design. Antimicrob Agents Chemother, 56: 4625–4629, 2012.
2.
AraiH, HayashiM, KuroiA, IshiiM, and IgarashiY. Transcriptional regulation of the flavohemoglobin gene for aerobic nitric oxide detoxification by the second nitric oxide-responsive regulator of Pseudomonas aeruginosa. J Bacteriol, 187: 3960–3968, 2005.
3.
BarrowK and KwonDH. Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother, 53: 5150–5154, 2009.
4.
BlairJM, WebberMA, BaylayAJ, OgboluDO, and PiddockLJ. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol, 13: 42–51, 2015.
5.
BrandenburgKS, RubinsteinI, SadikotRT, and OnyukselH. Polymyxin B self-associated with phospholipid nanomicelles. Pharm Dev Technol, 17: 654–660, 2012.
6.
CabotG, ZamoranoL, MoyaB, JuanC, NavasA, BlazquezJ, and OliverA. Evolution of Pseudomonas aeruginosa antimicrobial resistance and fitness under low and high mutation rates. Antimicrob Agents Chemother, 60: 1767–1778, 2016.
7.
CamposMA, VargasMA, RegueiroV, LlompartCM, AlbertiS, and BengoecheaJA. Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect Immun, 72: 7107–7114, 2004.
8.
ChangW, SmallDA, ToghrolF, and BentleyWE. Microarray analysis of Pseudomonas aeruginosa reveals induction of pyocin genes in response to hydrogen peroxide. BMC Genomics, 6: 115, 2005.
9.
ChungIY, KimBO, JangHJ, and ChoYH. Dual promoters of the major catalase (KatA) govern distinct survival strategies of Pseudomonas aeruginosa. Sci Rep, 6: 31185, 2016.
10.
CLSI. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobicaly: Approved Standard. M07-A10. Wayne, PA: Clinical and Laboratory Standards Institute, 2015.
11.
DaugelaviciusR, BakieneE, and BamfordDH. Stages of polymyxin B interaction with the Escherichia coli cell envelope. Antimicrob Agents Chemother, 44: 2969–2978, 2000.
12.
DongTG, DongS, CatalanoC, MooreR, LiangX, and MekalanosJJ. Generation of reactive oxygen species by lethal attacks from competing microbes. Proc Natl Acad Sci U S A, 112: 2181–2186, 2015.
13.
DreierJ and RuggeroneP. Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa. Front Microbiol, 6: 660, 2015.
14.
DuetzWA, RuediL, HermannR, O'ConnorK, BuchsJ, and WitholtB. Methods for intense aeration, growth, storage, and replication of bacterial strains in microtiter plates. Appl Environ Microbiol, 66: 2641–2646, 2000.
15.
FalagasME, RafailidisPI, and MatthaiouDK. Resistance to polymyxins: mechanisms, frequency and treatment options. Drug Resist Updat, 13: 132–138, 2010.
16.
FernandezL, GooderhamWJ, BainsM, McPheeJB, WiegandI, and HancockRE. Adaptive resistance to the “last hope” antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR-ParS. Antimicrob Agents Chemother, 54: 3372–3382, 2010.
17.
HelanderIM, KilpelainenI, and VaaraM. Increased substitution of phosphate groups in lipopolysaccharides and lipid A of the polymyxin-resistant pmrA mutants of Salmonella typhimurium: a 31P-NMR study. Mol Microbiol, 11: 481–487, 1994.
18.
KelnerMJ, BagnellR, and WelchKJ. Thioureas react with superoxide radicals to yield a sulfhydryl compound. Explanation for protective effect against paraquat. J Biol Chem, 265: 1306–1311, 1990.
19.
KimBO, ChungIY, and ChoYH. Differential expression of the major catalase, KatA in the two wild type Pseudomonas aeruginosa strains, PAO1 and PA14. J Microbiol, 57: 704–710, 2019.
20.
KimSH, ParkSY, HeoYJ, and ChoYH. Drosophila melanogaster-based screening for multihost virulence factors of Pseudomonas aeruginosa PA14 and identification of a virulence-attenuating factor, HudA. Infect Immun, 76: 4152–4162, 2008.
21.
KohanskiMA, DwyerDJ, HayeteB, LawrenceCA, and CollinsJJ. A common mechanism of cellular death induced by bactericidal antibiotics. Cell, 130: 797–810, 2007.
22.
LeeH, HsuFF, TurkJ, and GroismanEA. The PmrA-regulated pmrC gene mediates phosphoethanolamine modification of lipid A and polymyxin resistance in Salmonella enterica. J Bacteriol, 186: 4124–4133, 2004.
23.
LeeJS, HeoYJ, LeeJK, and ChoYH. KatA, the major catalase, is critical for osmoprotection and virulence in Pseudomonas aeruginosa PA14. Infect Immun, 73: 4399–4403, 2005.
24.
LeeJY and KoKS. Mutations and expression of PmrAB and PhoPQ related with colistin resistance in Pseudomonas aeruginosa clinical isolates. Diagn Microbiol Infect Dis, 78: 271–276, 2014.
25.
LiJ, NationRL, TurnidgeJD, MilneRW, CoulthardK, RaynerCR, and PatersonDL. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis, 6: 589–601, 2006.
26.
LimaMR, FerreiraGF, Nunes NetoWR, MonteiroJM, SantosARC, TavaresPB, DenadaiAML, BomfimMRQ, Dos SantosVL, MarquesSG, and de Souza MonteiroA. Evaluation of the interaction between polymyxin B and Pseudomonas aeruginosa biofilm and planktonic cells: reactive oxygen species induction and zeta potential. BMC Microbiol, 19: 115, 2019.
27.
LineL, AlhedeM, KolpenM, KuhlM, CiofuO, BjarnsholtT, MoserC, ToyofukuM, NomuraN, HoibyN, and JensenPO. Physiological levels of nitrate support anoxic growth by denitrification of Pseudomonas aeruginosa at growth rates reported in cystic fibrosis lungs and sputum. Front Microbiol, 5: 554, 2014.
28.
LiuY and ImlayJA. Cell death from antibiotics without the involvement of reactive oxygen species. Science, 339: 1210–1213, 2013.
29.
MasudaN, SakagawaE, and OhyaS. Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother, 39: 645–649, 1995.
30.
McPheeJB, LewenzaS, and HancockRE. Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa. Mol Microbiol, 50: 205–217, 2003.
MoskowitzSM, ErnstRK, and MillerSI. PmrAB, a two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A. J Bacteriol, 186: 575–579, 2004.
33.
MurrayJL, KwonT, MarcotteEM, and WhiteleyM. Intrinsic antimicrobial resistance determinants in the Superbug Pseudomonas aeruginosa. mBio, 6: e01603-15, 2015.
34.
NelsonBC, EirasDP, Gomez-SimmondsA, LooAS, SatlinMJ, JenkinsSG, WhittierS, CalfeeDP, FuruyaEY, and KubinCJ. Clinical outcomes associated with polymyxin B dose in patients with bloodstream infections due to carbapenem-resistant Gram-negative rods. Antimicrob Agents Chemother, 59: 7000–7006, 2015.
35.
OkamotoK, GotohN, and NishinoT. Pseudomonas aeruginosa reveals high intrinsic resistance to penem antibiotics: penem resistance mechanisms and their interplay. Antimicrob Agents Chemother, 45: 1964–1971, 2001.
36.
SampsonTR, LiuX, SchroederMR, KraftCS, BurdEM, and WeissDS. Rapid killing of Acinetobacter baumannii by polymyxins is mediated by a hydroxyl radical death pathway. Antimicrob Agents Chemother, 56: 5642–5649, 2012.
37.
SchurekKN, SampaioJL, KifferCR, SintoS, MendesCM, and HancockRE. Involvement of pmrAB and phoPQ in polymyxin B adaptation and inducible resistance in non-cystic fibrosis clinical isolates of Pseudomonas aeruginosa. Antimicrob Agents Chemother, 53: 4345–4351, 2009.
38.
TeuberM. Phosphorylation of methyl-alpha-D-glucopyranoside in polymyxin B-treated. Salmonella typhimurium J Bacteriol, 100: 1417–1419, 1969.
39.
TrunkK, BenkertB, QuackN, MunchR, ScheerM, GarbeJ, JanschL, TrostM, WehlandJ, BuerJ, JahnM, SchobertM, and JahnD. Anaerobic adaptation in Pseudomonas aeruginosa: definition of the Anr and Dnr regulons. Environ Microbiol, 12: 1719–1733, 2010.
40.
WolfgangMC, KulasekaraBR, LiangX, BoydD, WuK, YangQ, MiyadaCG, and LoryS. Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A, 100: 8484–8489, 2003.
41.
YoonSS, HenniganRF, HilliardGM, OchsnerUA, ParvatiyarK, KamaniMC, AllenHL, DeKievitTR, GardnerPR, SchwabU, RoweJJ, IglewskiBH, McDermottTR, MasonRP, WozniakDJ, HancockRE, ParsekMR, NoahTL, BoucherRC, and HassettDJ. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis. Dev Cell, 3: 593–603, 2002.
42.
YoungML, BainsM, BellA, and HancockRE. Role of Pseudomonas aeruginosa outer membrane protein OprH in polymyxin and gentamicin resistance: isolation of an OprH-deficient mutant by gene replacement techniques. Antimicrob Agents Chemother, 36: 2566–2568, 1992.
43.
ZimmermannA, ReimmannC, GalimandM, and HaasD. Anaerobic growth and cyanide synthesis of Pseudomonas aeruginosa depend on anr, a regulatory gene homologous with fnr of Escherichia coli. Mol Microbiol, 5: 1483–1490, 1991.
44.
ZumftWG. Cell biology and molecular basis of denitrification. Microbiol Mol Biol Rev, 61: 533–616, 1997.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
